Cargando…

Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation

Augmentation of endogenous cannabinoid (eCB) signaling represents an emerging approach to the treatment of affective disorders. Cyclooxygenase-2 (COX-2) oxygenates arachidonic acid to form prostaglandins, but also inactivates eCBs in vitro. However, the viability of COX-2 as a therapeutic target for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hermanson, Daniel J., Hartley, Nolan D., Gamble-George, Joyonna, Brown, Naoko, Shonesy, Brian C., Kingsley, Phillip J., Colbran, Roger J., Reese, Jeffrey, Marnett, Lawrence J., Patel, Sachin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788575/ https://www.ncbi.nlm.nih.gov/pubmed/23912944 http://dx.doi.org/10.1038/nn.3480

Ejemplares similares

Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation
por: Bluett, R J, et al.
Publicado: (2014)

Endocannabinoid signalling modulates susceptibility to traumatic stress exposure
por: Bluett, Rebecca J., et al.
Publicado: (2017)

Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors
por: Bedse, Gaurav, et al.
Publicado: (2018)

Cyclooxygenase-2 inhibition reduces stress-induced affective pathology
por: Gamble-George, Joyonna Carrie, et al.
Publicado: (2016)

CaMKII is a novel regulator of diacylglycerol lipase-α and striatal endocannabinoid signaling
por: Shonesy, Brian C., et al.
Publicado: (2013)

Endocannabinoid Oxygenation by Cyclooxygenases, Lipoxygenases, and Cytochromes P450: Cross-Talk between the Eicosanoid and Endocannabinoid Signaling Pathways
por: Rouzer, Carol A., et al.
Publicado: (2011)

Substrate-Selective Inhibition of Cyclooxygenase-2: Development and Evaluation of Achiral Profen Probes
por: Windsor, Matthew A., et al.
Publicado: (2012)

Characterization of an AM404 Analogue, N-(3-Hydroxyphenyl)arachidonoylamide, as a Substrate and Inactivator of Prostaglandin Endoperoxide Synthase
por: Turman, Melissa V., et al.
Publicado: (2009)

Differential Sensitivity and Mechanism of Inhibition of COX-2 Oxygenation of Arachidonic Acid and 2-Arachidonoylglycerol by Ibuprofen and Mefenamic Acid
por: Prusakiewicz, Jeffery J., et al.
Publicado: (2009)

Structural and Chemical Biology of the Interaction of Cyclooxygenase with Substrates and Non-Steroidal Anti-Inflammatory Drugs
por: Rouzer, Carol A., et al.
Publicado: (2020)

The 2′-Trifluoromethyl Analogue of Indomethacin Is a Potent and Selective COX-2 Inhibitor
por: Blobaum, Anna L., et al.
Publicado: (2013)

Discovery of Furanone-Based Radiopharmaceuticals for Diagnostic Targeting of COX-1 in Ovarian Cancer
por: Uddin, Md. Jashim, et al.
Publicado: (2019)

Detection of tyrosine kinase inhibitors-induced COX-2 expression in bladder cancer by fluorocoxib A
por: Bourn, Jennifer, et al.
Publicado: (2019)

The endocannabinoid system in anxiety, fear memory and habituation
por: Ruehle, S, et al.
Publicado: (2012)

The endocannabinoid system in modulating fear, anxiety, and stress 
por: Maldonado, Rafael, et al.
Publicado: (2020)

COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARδ activation
por: Ghosh, Mallika, et al.
Publicado: (2007)

In Parkinson's patient-derived dopamine neurons, the triplication of α-synuclein locus induces distinctive firing pattern by impeding D2 receptor autoinhibition
por: Lin, Min, et al.
Publicado: (2021)

Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review
por: Hasbi, Ahmed, et al.
Publicado: (2023)

The Endocannabinoid System of Animals
por: Silver, Robert J.
Publicado: (2019)

Cannabinoids, Endocannabinoids and Sleep
por: Kesner, Andrew J., et al.
Publicado: (2020)

Role of endocannabinoid signaling in a septohabenular pathway in the regulation of anxiety- and depressive-like behavior
por: Vickstrom, Casey R., et al.
Publicado: (2020)

The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics
por: Ahmed, Mashal, et al.
Publicado: (2021)

Racial and ethnic differences in the association of social cohesion and social capital with HIV testing
por: Ransome, Yusuf, et al.
Publicado: (2022)

Functional Implications of Biochemical and Molecular Characteristics of Donation After Circulatory Death Livers
por: Masuzaki, Ryota, et al.
Publicado: (2015)

Genetic variation in the endocannabinoid system and response to Cognitive Behavior Therapy for child anxiety disorders
por: Lester, Kathryn J., et al.
Publicado: (2016)

Inflammation and Cancer: Chemical Approaches to Mechanisms, Imaging, and Treatment
por: Marnett, Lawrence J.
Publicado: (2012)

The Endocannabinoid System, Cannabinoids, and Pain
por: Fine, Perry G., et al.
Publicado: (2013)

The peroxidation-derived DNA adduct, 6-oxo-M(1)dG, is a strong block to replication by human DNA polymerase η
por: Richie-Jannetta, Robyn, et al.
Publicado: (2023)

Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses
por: Hill, Matthew N, et al.
Publicado: (2013)

Design and function of targeted endocannabinoid nanoparticles
por: Barrie, N., et al.
Publicado: (2022)

Endocannabinoids and Schizophrenia
por: Desfossés, Joëlle, et al.
Publicado: (2010)

Endocannabinoids and Reproduction
por: Meccariello, Rosaria, et al.
Publicado: (2014)

Endocannabinoids and Immunity
por: Chiurchiù, Valerio
Publicado: (2016)

Endocannabinoids in the Gut
por: DiPatrizio, Nicholas V.
Publicado: (2016)

Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer
por: Wilson, Andrew J., et al.
Publicado: (2015)

The Endocannabinoid System Contributes to Electroacupuncture Analgesia
por: MacDonald, Iona J., et al.
Publicado: (2021)

Circulating endocannabinoid concentrations in grieving adults
por: Harfmann, Elisabeth J., et al.
Publicado: (2020)

Selection of Monoclonal Antibodies Against 6-oxo-M(1)dG and Their Use in an LC-MS/MS Assay for the Presence of 6-oxo-M(1)dG in Vivo
por: Akingbade, Dapo, et al.
Publicado: (2012)

Endocannabinoid Signaling Regulates Sleep Stability
por: Pava, Matthew J., et al.
Publicado: (2016)

Differential usage of COX-1 and COX-2 in prostaglandin production by mast cells and basophils
por: Bando, Tomoyuki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0fob0fhg5j5pms623o1s6nlab8